Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E Carson

Showing results (241-250 of 360) with videos related to

Pageof 36
Sort By:
IEEE Transactions on Radiation and Plasma Medical Sciences|December 25, 2025
Development and Initial Evaluation of 3D-printed High Resolution Brain Phantom for PETCynthia Lo, Ekaterina Shanina, Paul Gravel, et al.
Biological Psychiatry|September 17, 2013
Imaging glutamate homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography radiotracer [(11)C]ABP688 and magnetic resonance spectroscopyDiana Martinez, Mark Slifstein, Nabeel Nabulsi, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 3, 2015
Receptor Occupancy of the κ-Opioid Antagonist LY2456302 Measured with Positron Emission Tomography and the Novel Radiotracer 11C-LY2795050Mika Naganawa, Gemma L Dickinson, Ming-Qiang Zheng, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 28, 2022
Imaging the fetal nonhuman primate brain with SV2A positron emission tomography (PET)Samantha Rossano, Takuya Toyonaga, Eric Berg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 11, 2021
A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: synthesis and preclinical characterization of [<sup>18</sup>F]SDM-16Chao Zheng, Daniel Holden, Ming-Qiang Zheng, et al.
Neuroimage|May 22, 2014
Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242Mika Naganawa, Leslie K Jacobsen, Ming-Qiang Zheng, et al.
Journal of Psychiatric Research|March 19, 2023
Reductions in synaptic marker SV2A in early-course SchizophreniaJong H Yoon, Zhener Zhang, Elizabeth Mormino, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 6, 2015
Test-retest reproducibility of the metabotropic glutamate receptor 5 ligand [¹⁸F]FPEB with bolus plus constant infusion in humansEunkyung Park, Jenna M Sullivan, Beata Planeta, et al.
Drug and Alcohol Dependence|July 13, 2015
A preliminary study of dopamine D2/3 receptor availability and social status in healthy and cocaine dependent humans imaged with [(11)C](+)PHNODavid Matuskey, Edward C Gaiser, Jean-Dominique Gallezot, et al.
Annals of Neurology|January 19, 2020
Synaptic Changes in Parkinson Disease Assessed with in vivo ImagingDavid Matuskey, Sule Tinaz, Kyle C Wilcox, et al.
Pageof 36

Showing results (241-250 of 360) with videos related to

Sort By:
Pageof 36
IEEE Transactions on Radiation and Plasma Medical Sciences|December 25, 2025
Development and Initial Evaluation of 3D-printed High Resolution Brain Phantom for PETCynthia Lo, Ekaterina Shanina, Paul Gravel, et al.
Biological Psychiatry|September 17, 2013
Imaging glutamate homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography radiotracer [(11)C]ABP688 and magnetic resonance spectroscopyDiana Martinez, Mark Slifstein, Nabeel Nabulsi, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 3, 2015
Receptor Occupancy of the κ-Opioid Antagonist LY2456302 Measured with Positron Emission Tomography and the Novel Radiotracer 11C-LY2795050Mika Naganawa, Gemma L Dickinson, Ming-Qiang Zheng, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 28, 2022
Imaging the fetal nonhuman primate brain with SV2A positron emission tomography (PET)Samantha Rossano, Takuya Toyonaga, Eric Berg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 11, 2021
A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: synthesis and preclinical characterization of [<sup>18</sup>F]SDM-16Chao Zheng, Daniel Holden, Ming-Qiang Zheng, et al.
Neuroimage|May 22, 2014
Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242Mika Naganawa, Leslie K Jacobsen, Ming-Qiang Zheng, et al.
Journal of Psychiatric Research|March 19, 2023
Reductions in synaptic marker SV2A in early-course SchizophreniaJong H Yoon, Zhener Zhang, Elizabeth Mormino, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 6, 2015
Test-retest reproducibility of the metabotropic glutamate receptor 5 ligand [¹⁸F]FPEB with bolus plus constant infusion in humansEunkyung Park, Jenna M Sullivan, Beata Planeta, et al.
Drug and Alcohol Dependence|July 13, 2015
A preliminary study of dopamine D2/3 receptor availability and social status in healthy and cocaine dependent humans imaged with [(11)C](+)PHNODavid Matuskey, Edward C Gaiser, Jean-Dominique Gallezot, et al.
Annals of Neurology|January 19, 2020
Synaptic Changes in Parkinson Disease Assessed with in vivo ImagingDavid Matuskey, Sule Tinaz, Kyle C Wilcox, et al.
Pageof 36